The Gilead pact signed between Jubilant Life Sciences' subsidiary Jubilant Generics Ltd and Gilead, will grant the former the right to register, manufacture and sell the latter's investigation drug, remdesivir - a potential therapy for Covid-19.
from Top Business News- News18.com
Read The Rest:timesnownews...
from Top Business News- News18.com
Read The Rest:timesnownews...
Jubilant Life Sciences Shares Jump Five Percent on Gilead Pact for Covid-19 Therapy Drug
Reviewed by Team Exprssnews
on
May 13, 2020
Rating:
No comments: